ABUS logo

Arbutus Biopharma Corporation (ABUS) EBITDA

annual EBITDA:

-$68.59M+$8.04M(+10.49%)
December 31, 2024

Summary

  • As of today (August 20, 2025), ABUS annual EBITDA is -$68.59 million, with the most recent change of +$8.04 million (+10.49%) on December 31, 2024.
  • During the last 3 years, ABUS annual EBITDA has risen by +$1.30 million (+1.86%).
  • ABUS annual EBITDA is now -1384.27% below its all-time high of $5.34 million, reached on December 31, 2006.

Performance

ABUS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

quarterly EBITDA:

$1.92M+$14.62M(+115.15%)
June 30, 2025

Summary

  • As of today (August 20, 2025), ABUS quarterly EBITDA is $1.92 million, with the most recent change of +$14.62 million (+115.15%) on June 30, 2025.
  • Over the past year, ABUS quarterly EBITDA has increased by +$22.94 million (+109.15%).
  • ABUS quarterly EBITDA is now -76.62% below its all-time high of $8.23 million, reached on March 1, 2005.

Performance

ABUS quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

TTM EBITDA:

-$39.52M+$22.94M(+36.73%)
June 30, 2025

Summary

  • As of today (August 20, 2025), ABUS TTM EBITDA is -$39.52 million, with the most recent change of +$22.94 million (+36.73%) on June 30, 2025.
  • Over the past year, ABUS TTM EBITDA has increased by +$41.47 million (+51.20%).
  • ABUS TTM EBITDA is now -579.78% below its all-time high of $8.24 million, reached on March 1, 2007.

Performance

ABUS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

ABUS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.5%+109.2%+51.2%
3 y3 years+1.9%+114.2%+35.4%
5 y5 years+1.0%+115.4%+28.9%

ABUS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-11.0%+10.5%at high+109.2%at high+51.2%
5 y5-year-24.1%+10.5%at high+109.2%at high+51.2%
alltimeall time-1384.3%+10.5%-76.6%+108.5%-579.8%+51.2%

ABUS EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$1.92M(-115.2%)
-$39.52M(-36.7%)
Mar 2025
-
-$12.70M(+9.3%)
-$62.46M(-8.9%)
Dec 2024
-$68.59M(-10.5%)
-$11.62M(-32.2%)
-$68.59M(-11.1%)
Sep 2024
-
-$17.14M(-18.5%)
-$77.14M(-4.8%)
Jun 2024
-
-$21.02M(+11.6%)
-$80.99M(+3.0%)
Mar 2024
-
-$18.83M(-6.6%)
-$78.65M(+2.6%)
Dec 2023
-$76.63M(+24.0%)
-$20.16M(-3.9%)
-$76.63M(-0.6%)
Sep 2023
-
-$20.98M(+12.3%)
-$77.11M(+5.1%)
Jun 2023
-
-$18.68M(+11.1%)
-$73.38M(+7.6%)
Mar 2023
-
-$16.81M(-18.6%)
-$68.22M(+10.4%)
Dec 2022
-$61.80M(-11.6%)
-$20.65M(+19.7%)
-$61.80M(+0.8%)
Sep 2022
-
-$17.25M(+27.6%)
-$61.33M(+0.2%)
Jun 2022
-
-$13.52M(+30.2%)
-$61.18M(-6.1%)
Mar 2022
-
-$10.38M(-48.6%)
-$65.17M(-6.8%)
Dec 2021
-$69.90M(+26.4%)
-$20.18M(+18.0%)
-$69.90M(+6.9%)
Sep 2021
-
-$17.11M(-2.3%)
-$65.41M(+4.0%)
Jun 2021
-
-$17.51M(+15.9%)
-$62.91M(+8.6%)
Mar 2021
-
-$15.10M(-3.7%)
-$57.92M(+4.7%)
Dec 2020
-$55.29M(-20.2%)
-$15.69M(+7.4%)
-$55.29M(+5.8%)
Sep 2020
-
-$14.61M(+16.7%)
-$52.28M(-6.0%)
Jun 2020
-
-$12.52M(+0.3%)
-$55.59M(-12.2%)
Mar 2020
-
-$12.48M(-1.6%)
-$63.35M(-8.6%)
Dec 2019
-$69.32M(+1.9%)
-$12.68M(-29.3%)
-$69.32M(-3.7%)
Sep 2019
-
-$17.92M(-11.6%)
-$71.95M(+0.4%)
Jun 2019
-
-$20.28M(+9.9%)
-$71.64M(+2.0%)
Mar 2019
-
-$18.45M(+20.5%)
-$70.25M(+3.3%)
Dec 2018
-$68.01M(-0.1%)
-$15.31M(-13.0%)
-$67.99M(-4.9%)
Sep 2018
-
-$17.61M(-6.8%)
-$71.51M(+8.0%)
Jun 2018
-
-$18.89M(+16.7%)
-$66.20M(-0.2%)
Mar 2018
-
-$16.18M(-14.1%)
-$66.32M(-2.6%)
Dec 2017
-$68.11M(+1.3%)
-$18.83M(+53.0%)
-$68.11M(-0.4%)
Sep 2017
-
-$12.30M(-35.3%)
-$68.36M(-4.7%)
Jun 2017
-
-$19.00M(+5.8%)
-$71.74M(-5.0%)
Mar 2017
-
-$17.96M(-5.9%)
-$75.50M(+4.1%)
Dec 2016
-$67.20M(+84.8%)
-$19.08M(+21.7%)
-$72.50M(+24.4%)
Sep 2016
-
-$15.68M(-31.1%)
-$58.29M(+2.4%)
Jun 2016
-
-$22.77M(+52.2%)
-$56.90M(+29.5%)
Mar 2016
-
-$14.96M(+207.1%)
-$43.94M(+20.8%)
Dec 2015
-$36.37M(+12.1%)
-$4.87M(-65.9%)
-$36.37M(-13.7%)
Sep 2015
-
-$14.29M(+45.7%)
-$42.13M(+22.0%)
Jun 2015
-
-$9.81M(+32.8%)
-$34.55M(+1.6%)
Mar 2015
-
-$7.39M(-30.5%)
-$34.01M(+4.8%)
Dec 2014
-$32.44M(+181.1%)
-$10.63M(+58.5%)
-$32.44M(+34.6%)
Sep 2014
-
-$6.71M(-27.6%)
-$24.10M(+15.5%)
Jun 2014
-
-$9.27M(+59.2%)
-$20.86M(+43.6%)
Mar 2014
-
-$5.82M(+154.3%)
-$14.52M(+25.3%)
Dec 2013
-$11.54M(-4.3%)
-$2.29M(-34.0%)
-$11.59M(-22.9%)
Sep 2013
-
-$3.47M(+18.3%)
-$15.04M(+14.5%)
Jun 2013
-
-$2.94M(+1.7%)
-$13.13M(+4.8%)
Mar 2013
-
-$2.89M(-49.7%)
-$12.52M(+4.1%)
Dec 2012
-$12.06M
-$5.74M(+266.7%)
-$12.03M(+48.1%)
Sep 2012
-
-$1.57M(-32.9%)
-$8.12M(+1.4%)
Jun 2012
-
-$2.33M(-2.5%)
-$8.02M(-12.7%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$2.39M(+30.2%)
-$9.18M(-5.0%)
Dec 2011
-$9.63M(+78.4%)
-$1.84M(+26.0%)
-$9.67M(-27.4%)
Sep 2011
-
-$1.46M(-58.3%)
-$13.32M(+60.0%)
Jun 2011
-
-$3.50M(+21.4%)
-$8.33M(+0.0%)
Mar 2011
-
-$2.88M(-47.5%)
-$8.33M(-10.3%)
Dec 2010
-$5.40M(-17.8%)
-$5.49M(-255.2%)
-$9.28M(+64.1%)
Sep 2010
-
$3.54M(-201.2%)
-$5.66M(-49.0%)
Jun 2010
-
-$3.49M(-8.8%)
-$11.09M(+22.2%)
Mar 2010
-
-$3.83M(+105.4%)
-$9.07M(+37.2%)
Dec 2009
-$6.57M(-20.3%)
-$1.87M(-1.9%)
-$6.62M(+20.4%)
Sep 2009
-
-$1.90M(+28.8%)
-$5.49M(-5.8%)
Jun 2009
-
-$1.48M(+7.5%)
-$5.83M(-37.0%)
Mar 2009
-
-$1.37M(+84.6%)
-$9.26M(+7.5%)
Dec 2008
-$8.24M(-392.8%)
-$743.60K(-66.8%)
-$8.61M(+11.9%)
Sep 2008
-
-$2.24M(-54.2%)
-$7.70M(+103.0%)
Jun 2008
-
-$4.90M(+571.9%)
-$3.79M(-374.3%)
Mar 2008
-
-$729.00K(-525.3%)
$1.38M(-50.7%)
Dec 2007
$2.81M(-47.3%)
$171.40K(-89.7%)
$2.80M(+4.4%)
Sep 2007
-
$1.66M(+500.4%)
$2.68M(-47.1%)
Jun 2007
-
$277.00K(-59.9%)
$5.07M(-38.5%)
Mar 2007
-
$691.00K(+1211.2%)
$8.24M(+50.8%)
Dec 2006
$5.34M(+840.5%)
-
-
Dec 2006
-
$52.70K(-98.7%)
$5.46M(+98.8%)
Sep 2006
-
$4.05M(+17.6%)
$2.75M(-181.9%)
Jun 2006
-
$3.44M(-265.4%)
-$3.36M(-66.0%)
Mar 2006
-
-$2.08M(-21.8%)
-$9.86M(-2290.1%)
Dec 2005
$567.90K(-103.4%)
-
-
Dec 2005
-
-$2.66M(+29.4%)
$450.30K(-120.6%)
Sep 2005
-
-$2.06M(-32.8%)
-$2.19M(-48.8%)
Jun 2005
-
-$3.06M(-137.2%)
-$4.27M(-14.9%)
Mar 2005
-
$8.23M(-255.3%)
-$5.02M(-69.8%)
Dec 2004
-$16.82M(-34.6%)
-
-
Dec 2004
-
-$5.30M(+27.9%)
-$16.63M(-13.8%)
Sep 2004
-
-$4.14M(+8.9%)
-$19.30M(-8.2%)
Jun 2004
-
-$3.81M(+12.6%)
-$21.01M(+22.1%)
Mar 2004
-
-$3.38M(-57.6%)
-$17.21M(+24.5%)
Dec 2003
-$25.71M(+16.2%)
-
-
Dec 2003
-
-$7.97M(+36.0%)
-$13.83M(+0.2%)
Sep 2003
-
-$5.86M(-26.3%)
-$13.80M(-37.6%)
Dec 2002
-$22.12M(+72.3%)
-
-
Dec 2002
-
-$7.94M(+25.2%)
-$22.12M(+15.1%)
Sep 2002
-
-$6.35M(+77.5%)
-$19.23M(+24.4%)
Jun 2002
-
-$3.57M(-16.0%)
-$15.45M(+3.2%)
Mar 2002
-
-$4.25M(-15.8%)
-$14.97M(+14.1%)
Dec 2001
-$12.84M(+31.6%)
-
-
Dec 2001
-
-$5.05M(+96.5%)
-$13.12M(+62.6%)
Sep 2001
-
-$2.57M(-17.0%)
-$8.07M(+46.8%)
Jun 2001
-
-$3.10M(+29.0%)
-$5.50M(+129.0%)
Mar 2001
-
-$2.40M
-$2.40M
Dec 2000
-$9.76M(+34.9%)
-
-
Dec 1999
-$7.23M(-17.4%)
-
-
Dec 1998
-$8.75M(+28.1%)
-
-
Dec 1997
-$6.83M
-
-

FAQ

  • What is Arbutus Biopharma Corporation annual EBITDA?
  • What is the all time high annual EBITDA for Arbutus Biopharma Corporation?
  • What is Arbutus Biopharma Corporation annual EBITDA year-on-year change?
  • What is Arbutus Biopharma Corporation quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Arbutus Biopharma Corporation?
  • What is Arbutus Biopharma Corporation quarterly EBITDA year-on-year change?
  • What is Arbutus Biopharma Corporation TTM EBITDA?
  • What is the all time high TTM EBITDA for Arbutus Biopharma Corporation?
  • What is Arbutus Biopharma Corporation TTM EBITDA year-on-year change?

What is Arbutus Biopharma Corporation annual EBITDA?

The current annual EBITDA of ABUS is -$68.59M

What is the all time high annual EBITDA for Arbutus Biopharma Corporation?

Arbutus Biopharma Corporation all-time high annual EBITDA is $5.34M

What is Arbutus Biopharma Corporation annual EBITDA year-on-year change?

Over the past year, ABUS annual EBITDA has changed by +$8.04M (+10.49%)

What is Arbutus Biopharma Corporation quarterly EBITDA?

The current quarterly EBITDA of ABUS is $1.92M

What is the all time high quarterly EBITDA for Arbutus Biopharma Corporation?

Arbutus Biopharma Corporation all-time high quarterly EBITDA is $8.23M

What is Arbutus Biopharma Corporation quarterly EBITDA year-on-year change?

Over the past year, ABUS quarterly EBITDA has changed by +$22.94M (+109.15%)

What is Arbutus Biopharma Corporation TTM EBITDA?

The current TTM EBITDA of ABUS is -$39.52M

What is the all time high TTM EBITDA for Arbutus Biopharma Corporation?

Arbutus Biopharma Corporation all-time high TTM EBITDA is $8.24M

What is Arbutus Biopharma Corporation TTM EBITDA year-on-year change?

Over the past year, ABUS TTM EBITDA has changed by +$41.47M (+51.20%)
On this page